Dr. Gi-Byoung Nam, Dr. Dukwoo Park and Dr. C Michael Gibson Discuss: EPIC-CAD – Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary artery disease September 1, 2024 Disclosures: TBD
Dr. Rabea Asleh and Dr. C Michael Gibson Discuss: Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction September 1, 2024 Disclosures: TBD
Dr. Manesh Patel and Dr. C Michael Gibson Discuss: OCEANIC-AF – Asundexian versus apixaban in patients with atrial fibrillation September 1, 2024
Dr. Dipak Kotecha and Dr. C Michael Gibson Discuss: STEEER-AF – Stroke prevention and rhythm control therapy September 1, 2024 Disclosures: TBD
Dr. Dirk-Jan van Ginkel and Dr. C Michael Gibson Discuss: POPular PAUSE TAVI – Continuation or interruption of oral anticoagulation during TAVI? August 31, 2024 Disclosures: TBD
Dr. Stefan James and Dr. C Michael Gibson Discuss: SWEDEGRAFT – No-touch vein grafts in coronary artery bypass grafting August 31, 2024 Disclosures: TBD
Dr. Jung-Min Ahn and Dr. C Michael Gibson Discuss: ASSURE DES – Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery August 31, 2024 Disclosures: TBD
Dr. Erwan Donal and Dr. C Michael Gibson Discuss: Tri.fr trial – Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation August 31, 2024 Disclosures: TBD
Dr. Volker Rudolph, Dr. Stephan Baldus and Dr. C Michael Gibson Discuss: MATTERHORN – Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation August 31, 2024 Disclosures: TBD
Dr. Stefan Anker and Dr. C Michael Gibson Discuss: RESHAPE-HF2 – Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure August 31, 2024 Disclosures: TBD
